Additional Therapeutic Experience

Expertise doesn’t come easy, nor is it a word we take lightly. It comes with a relentless focus, the drive to always be better, and most importantly of all – decades of hands-on experience.

While our therapeutic expertise currently lies in the core areas where we’re most accomplished, our foundational commitment to constantly improve health, extend life, and enhance quality of life has led us to a wealth of clinical experience over the years.

Care that transcends therapeutic area

Our clients break new ground each and every day – opening doors and advancing treatments and cures for all types of patients who are running out of options. It’s this inspiring commitment that fuels our fire to continually push further, grow our collective skill set, successfully execute virtual trials, and ultimately maximize the reach of our helping hand.

Because after all, experience is what drives us.

Join us as we push the boundaries of what’s possible on our endless quest to heal the world. We proudly invite you to experience Rho.

More than 50% of our teams

have been at Rho for 5 years or more


of clients rated Rho superior or very superior compared to other CROs

More than


publications in more than 96 journals

Indications Experience

  • Dental and Craniofacial

    ● Behavioral interventions
    ● Craniosynostosis
    ● Taste sensitivity
    ● Periodontal surgery
    ● Fluoride exposure
    ● Oral mucositis
    ● Cleft palate
    ● Craniofacial microsomia
    ● Dry mouth
    ● Teeth whitening
    ● Periodontal infections/gingivitis
    ● Dental plaque
    ● Oral irritation and sensitization
    ● Dental caries
    ● Oral wound healing
    ● Temporomandibular disorder
    ● Salivary gland dysfunction
    ● Oral cancer
    ● Sjögren’s syndrome

  • Dermatology

    ● Acne vulgaris
    ● Alopecia Areata
    ● Atopic dermatitis
    ● Pruritus
    ● Psoriasis
    ● Submental skin laxity
    ● Wound healing

  • Hematology

    ● Hemophilia A and B
    ● von Willebrand disease
    ● Sickle cell disease
    ● Atypical hemolytic-uremic syndrome (aHUS)
    ● Refractory hematologic malignancies
    ● Chronic myelogenous leukemia
    ● Progressive B-cell chronic lymphocytic leukemia
    ● Acute leukemia
    ● Myelodysplasia
    ● Indolent non-Hodgkin’s lymphoma

  • Ophthalmology

    ● Ocular Inflammation
    ● Diabetic Macular Edema
    ● Contact lens
    ● Contact Solution
    ● Intraocular Pressure
    ● Post-Op Pain
    ● Bacterial Conjunctivitis
    ● Glaucoma
    ● Ocular Hypertension
    ● Dry Eye, Cataracts
    ● Age-Related Macular
    ● Degeneration
    ● Blepharitis
    ● Presbyopia
    ● Behcet’s Disease Uveitis
    ● Pars Plana Vitrectomy

  • Pediatrics

    ● ADHD
    ● Otitis media
    ● Rare and ultra-rare diseases
    ● Cystic fibrosis
    ● Peanut allergy
    ● Asthma
    ● Transplant (liver, renal, kidney, heart, lung)
    ● Dental caries
    ● Periodontal disease
    ● Type 1 diabetes

  • Infectious Disease

    ● Influenza
    ● Pneumonia
    ● MSRA
    ● Anthrax
    ● Tuberculosis
    ● HIV / AIDs
    ● Cholera
    ● Hepatitis B
    ● Hepatitis C
    ● HPV
    ● Herpes Zoster
    ● Sepsis

  • Vaccine

    ● Influenza
    ● Anthrax
    ● Cholera
    ● HIV / SIV
    ● Yellow Fever
    ● Genital HSV-2
    ● Varicella


Managing the Risks of Implementing E6R2

Successful implementation of RBQM is a challenge many in our industry are facing. To understand what it is and how it impacts the management of your clinical trial, this webinar will address what exactly E6R2 is. We will use Rho as a case study for designing and implementing a strategy, discuss common misconceptions, and review lessons Rho has learned through implementation of RBQM.

Watch Webinar
Marina Acosta Enslen

Marina Acosta Enslen

Director, Clinical Management

Nick Poulson

Nick Poulson, Ph.D

Senior Project Manager


Missy Lavinder

Senior Project Manager

Success Stories

Achieving Success After Rescuing a Neglected Study

Read more

Delivering Topline Results 36 Hours After Database Lock

Read more

Overcoming Enrollment Obstacles to Exceed Sponsor Expectations

Read more